| Literature DB >> 33946764 |
Shun-Yi Jian1,2, Salim Levent Aktug3, Hsuan-Ti Huang4,5,6,7,8,9, Cheng-Jung Ho4,5,6,7,8,9, Sung-Yen Lin4,5,6,7,8,9, Chung-Hwan Chen4,5,6,7,8,9,10,11, Min-Wen Wang12, Chun-Chieh Tseng13.
Abstract
Micro arc oxidation (MAO) is a prominent surface treatment to form bioceramic coating layers with beneficial physical, chemical, and biological properties on the metal substrates for biomaterial applications. In this study, MAO treatment has been performed to modify the surface characteristics of AZ31 Mg alloy to enhance the biocompatibility and corrosion resistance for implant applications by using an electrolytic mixture of Ca3(PO4)2 and C10H16N2O8 (EDTA) in the solutions. For this purpose, the calcium phosphate (Ca-P) containing thin film was successfully fabricated on the surface of the implant material. After in-vivo implantation into the rabbit bone for four weeks, the apparent growth of soft tissues and bone healing effects have been documented. The morphology, microstructure, chemical composition, and phase structures of the coating were identified by SEM, XPS, and XRD. The corrosion resistance of the coating was analyzed by polarization and salt spray test. The coatings consist of Ca-P compounds continuously have proliferation activity and show better corrosion resistance and lower roughness in comparison to mere MAO coated AZ31. The corrosion current density decreased to approximately 2.81 × 10-7 A/cm2 and roughness was reduced to 0.622 μm. Thus, based on the results, it was anticipated that the development of degradable materials and implants would be feasible using this method. This study aims to fabricate MAO coatings for orthopedic magnesium implants that can enhance bioactivity, biocompatibility, and prevent additional surgery and implant-related infections to be used in clinical applications.Entities:
Keywords: EDTA; SBF; biodegradability; magnesium alloy; micro-arc oxidation (MAO)
Mesh:
Substances:
Year: 2021 PMID: 33946764 PMCID: PMC8124595 DOI: 10.3390/ijms22094706
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Electrolyte composition and operation condition for the MAO treatment.
| Name | Na2SiO3 | NaOH | Na3PO4 | Ca3(PO4)2 | EDTA |
|---|---|---|---|---|---|
| EDTA2.5 | 60 g/L | 70 g/L | 20 g/L | 7.0 g/L | 2.5 g/L |
| EDTA5.0 | 60 g/L | 70 g/L | 20 g/L | 7.0 g/L | 5.0 g/L |
| EDTA7.5 | 60 g/L | 70 g/L | 20 g/L | 7.0 g/L | 7.5 g/L |
Figure 1Test setup for the locking force (a) bone screw, (b) D3 bionic bone, (c) custom-made testing, (d) pull up testing of the AZ31 Mg alloy bone screw
Figure 2SEM morphology of the AZ31 sample treated in the EDTA (a,b) 2.5 g; (c,d) 5.0 g; and (e,f) 7.5 g bath.
EDS analysis of the different Ca-P containing MAO samples on AZ31 Mg alloys
| Element-Atomic% | |||||||
|---|---|---|---|---|---|---|---|
| C | O | Ca | Mg | Al | Si | Total | |
| EDTA2.5 | 9.66 | 53.2 | - | 29.1 | 0.79 | 7.25 | 100 |
| EDTA5.0 | 10.3 | 53.8 | 0.75 | 27.9 | 0.7 | 6.55 | 100 |
| EDTA7.5 | 14.2 | 55.3 | 1.19 | 20.9 | 0.54 | 7.87 | 100 |
Figure 3Cross-section SEM morphology of the AZ31 sample treated in the EDTA (a) 2.5 g, (b) 5.0 g, and (c) 7.5 g bath.
Figure 4XRD patterns of the AZ31 sample treated in the EDTA 2.5, 5.0, and 7.5 g bath.
Figure 5Visual images of the Ca-P containing MAO samples treated in the EDTA 2.5, 5.0, and 7.5 g bath after 24 h of the salt spray test.
Figure 6Potentiodynamic polarization curves in SBF solution for the AZ31 sample treated in the various EDTA bath.
Figure 7Records of the cyclic hydrogen evolution in SBF solution for the AZ31 sample treated in the various EDTA bath.
Hydrogen evolution, surface roughness, and porosity of the AZ31 sample treated in the various EDTA bath
| Hydrogen Volumes | Hydrogen Evolution Corrosion Rate | Surface Roughness | Porosity | |
|---|---|---|---|---|
| EDTA2.5 | 11 ± 1.3 | 1.79 ± 0.38 | 0.85 ± 0.19 | 2.59 ± 0.47 |
| EDTA5.0 | 9 ± 1.0 | 1.47 ± 0.29 | 0.79 ± 0.14 | 2.23 ± 0.45 |
| EDTA7.5 | 8 ± 1.0 | 1.30 ± 0.21 | 0.62 ± 0.10 | 2.08 ± 0.45 |
Locking force of the AZ31 Mg alloy bone screw
| AZ31 Mg Alloy Bone Screw | |
|---|---|
| Locking force with non-immersed SBF | 308 ± 40 N |
| Locking force with immersed for 6 weeks | 285 ± 40 N |
| Residual locking force with immersed for 6 weeks | 92% |
| Locking force with immersed for 10 weeks | 265 ± 42 N |
| Residual locking force with immersed for 10 weeks | 86% |
Figure 8Morphology and confluence of L929 cells after being exposed to (a) the Ca-P containing MAO sample, (b) blank control, (c) positive control, and (d) negative control extracts.
Summary of cytotoxicity test results
| Extracts | Cell Morphology | Inhibition of Viability | Cytotoxicity |
|---|---|---|---|
| Ca-P containing MAO sample | 1 | <30% | None |
| Blank control | 0 | <30% | None |
| Positive control | 4 | 98.2% | Cytotoxicity |
| Negative control | 0 | <30% | None |
Figure 9XPS surface full spectrum and depth profile of the AZ31 sample treated in the EDTA (a,b) 0 g and (c,d) 7.5 g bath.
Content of Ca and P elements of MAO coated sample.
| Non-Immersed in SBF | After Immersed in SBF for 48 h | |||
|---|---|---|---|---|
| EDTA 0 g Bath | EDTA 7.5 g Bath | EDTA 0 G Bath | EDTA 7.5 g Bath | |
| Ca | 0% | 3.95% | 14.8% | 17.1% |
| P | 1.72% | 2.08% | 11.6% | 11.6% |
Figure 10After 48 h immersion in the SBF solution, the XPS surface full spectrum and depth profile of the AZ31 sample treated in the EDTA (a,b) 0 g and (c,d) 7.5 g bath.
Figure 11Plain X-ray of the AZ31 screw treated in the EDTA 7.5 g bath in the femoral shaft of a rabbit: (a) just implanted, (b) 2 weeks, and (c) 3 weeks.
Figure 12μCT reconstructed images showing the degradation processes of AZ31 bone-screw after implantation of (a) 4, (b) 8, and (c) 12 weeks.